United States · FDA National Drug Code directory
Tizanidne hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-612_628c23e5-c9ed-453b-a83e-1514d6b02912
- Product NDC
- 67877-612
- Form
- CAPSULE
- Composition / generic term
- Tizanidne hydrochloride
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190329
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 6 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (67877-612-05) · 67877-612-05
- 150 CAPSULE in 1 BOTTLE (67877-612-15) · 67877-612-15
- 1 BLISTER PACK in 1 CARTON (67877-612-33) / 10 CAPSULE in 1 BLISTER PACK · 67877-612-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →